New Directive introduces EU structures that will drive medtech innovation and demand
This article was originally published in Clinica
Executive Summary
The EU’s Directive on the application of patients’ rights in cross-border healthcare will have a fundamental impact on the medtech market of the future. New structures created by the Directive will particularly affect the areas of health technology assessment, e-health and the co-ordination of healthcare specialisations, particularly for rare disease.